JUMIA TECHNOLOGIES AG-ADR (JMIA)

US48138M1053 - ADR

6.66  0 (0%)

Premarket: 6.83 +0.17 (+2.55%)

Fundamental Rating

2

JMIA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 33 industry peers in the Broadline Retail industry. JMIA may be in some trouble as it scores bad on both profitability and health. JMIA does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year JMIA has reported negative net income.
In the past year JMIA has reported a negative cash flow from operations.
In the past 5 years JMIA always reported negative net income.
In the past 5 years JMIA always reported negative operating cash flow.

1.2 Ratios

JMIA has a Return On Assets of -71.09%. This is amonst the worse of the industry: JMIA underperforms 93.94% of its industry peers.
With a Return On Equity value of -262.81%, JMIA is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -71.09%
ROE -262.81%
ROIC N/A
ROA(3y)-55.41%
ROA(5y)-56.89%
ROE(3y)-113.91%
ROE(5y)-106.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of JMIA (58.03%) is better than 78.79% of its industry peers.
JMIA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for JMIA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.29%
GM growth 5Y10.91%

3

2. Health

2.1 Basic Checks

JMIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JMIA has been increased compared to 1 year ago.
JMIA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JMIA has been reduced compared to a year ago.

2.2 Solvency

JMIA has an Altman-Z score of -13.15. This is a bad value and indicates that JMIA is not financially healthy and even has some risk of bankruptcy.
JMIA's Altman-Z score of -13.15 is on the low side compared to the rest of the industry. JMIA is outperformed by 96.97% of its industry peers.
JMIA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
JMIA's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. JMIA outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -13.15
ROIC/WACCN/A
WACC7.16%

2.3 Liquidity

A Current Ratio of 1.27 indicates that JMIA should not have too much problems paying its short term obligations.
The Current ratio of JMIA (1.27) is worse than 66.67% of its industry peers.
A Quick Ratio of 1.19 indicates that JMIA should not have too much problems paying its short term obligations.
JMIA has a Quick ratio (1.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.19

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.86% over the past year.
Looking at the last year, JMIA shows a very negative growth in Revenue. The Revenue has decreased by -14.30% in the last year.
JMIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.14% yearly.
EPS 1Y (TTM)44.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q100%
Revenue 1Y (TTM)-14.3%
Revenue growth 3Y5.35%
Revenue growth 5Y4.14%
Revenue growth Q2Q5.67%

3.2 Future

Based on estimates for the next years, JMIA will show a very strong growth in Earnings Per Share. The EPS will grow by 24.47% on average per year.
Based on estimates for the next years, JMIA will show a small growth in Revenue. The Revenue will grow by 2.03% on average per year.
EPS Next Y65.31%
EPS Next 2Y34.77%
EPS Next 3Y24.47%
EPS Next 5YN/A
Revenue Next Year-4.65%
Revenue Next 2Y0.3%
Revenue Next 3Y2.03%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JMIA. In the last year negative earnings were reported.
Also next year JMIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

JMIA's earnings are expected to grow with 24.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.77%
EPS Next 3Y24.47%

0

5. Dividend

5.1 Amount

No dividends for JMIA!.
Industry RankSector Rank
Dividend Yield N/A

JUMIA TECHNOLOGIES AG-ADR

NYSE:JMIA (5/16/2024, 7:04:00 PM)

Premarket: 6.83 +0.17 (+2.55%)

6.66

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap673.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -71.09%
ROE -262.81%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 58.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 1.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)44.86%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y65.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.3%
Revenue growth 3Y5.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y